The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts

In spite of the progress in the treatment of lysosomal storage diseases (LSDs), in some of these disorders the available therapies show limited efficacy and a need exists to identify novel therapeutic strategies. We studied the combination of enzyme replacement and enzyme enhancement by pharmacologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Porto, Caterina, Cardone, Monica, Fontana, Federica, Rossi, Barbara, Tuzzi, Maria Rosaria, Tarallo, Antonietta, Barone, Maria Vittoria, Andria, Generoso, Parenti, Giancarlo
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835191/
https://www.ncbi.nlm.nih.gov/pubmed/19293774
http://dx.doi.org/10.1038/mt.2009.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835191/
https://www.ncbi.nlm.nih.gov/pubmed/19293774
http://dx.doi.org/10.1038/mt.2009.53

Ejemplares similares